Engineering

Education

Business Development

Administrative

Operations

Legal

Information Technology

Research

Finance

Program and Project Management

Founder & CEO

Chief Financial Officer & Chief Business Officer

Lilly-backed Absci banks $100m to progress endometriosis, hair loss therapy

Healthcare stocks have become a haven for investors ditching tech

Absci's ABS-201 Phase 1 Data De-Risks Hair Loss Program Ahead of Efficacy Readout, Truist Says

Absci Raises $100 Million In Equity To Fund AI-Designed Hair Loss And Endometriosis Program

General Interest

Absci is a data-first AI drug creation company designing differentiated therapeutics using generative AI. They are always on the lookout for extraordinary talent to help redefine the boundaries of science and innovation, encouraging candidates to submit general applications for future opportunities.